Free Trial

Integrated BioPharma (INBP) Short Interest Ratio & Short Volume

Integrated BioPharma logo
$0.32
0.00 (0.00%)
(As of 11/4/2024 ET)

Integrated BioPharma Short Interest Data

Integrated BioPharma (INBP) has a short interest of 200 shares. This marks a -60.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 11,067 shares to cover all short positions.

Current Short Interest
200 shares
Previous Short Interest
500 shares
Change Vs. Previous Month
-60.00%
Dollar Volume Sold Short
$50.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
30,100,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
2,000 shares
Average Trading Volume
11,067 shares
Today's Volume Vs. Average
18%
Short Selling Integrated BioPharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Integrated BioPharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INBP Short Interest Over Time

INBP Days to Cover Over Time

INBP Percentage of Float Shorted Over Time

Integrated BioPharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024200 shares $50.00 -60.0%N/A0 $0.25
9/30/2024500 shares $117.20 -28.6%N/A0.1 $0.23
9/15/2024700 shares $160.93 +600.0%N/A0 $0.23
8/31/2024100 shares $19.00 No ChangeN/A0 $0.19
8/15/2024100 shares $16.38 No ChangeN/A0 $0.16
7/31/2024100 shares $20.00 No ChangeN/A0.5 $0.20
7/15/2024100 shares $20.00 No ChangeN/A0.1 $0.20
6/30/2024100 shares $21.00 No ChangeN/A0.5 $0.21
6/15/2024100 shares $22.32 No ChangeN/A0.4 $0.22
5/31/2024100 shares $25.00 No ChangeN/A0.1 $0.25
5/15/2024100 shares $22.00 No ChangeN/A0 $0.22
4/30/2024100 shares $21.00 No ChangeN/A0.1 $0.21
4/15/2024100 shares $21.50 No ChangeN/A0 $0.22
11/15/20231,000 shares $270.00 -70.6%N/A0.1 $0.27
10/31/20233,400 shares $822.12 -15.0%N/A0.1 $0.24
10/15/20234,000 shares $1,060.00 +700.0%N/A0.7 $0.27
9/30/2023500 shares $140.00 -70.6%N/A0 $0.28
9/15/20231,700 shares $484.50 No ChangeN/A1.7 $0.29
8/31/20231,700 shares $477.70 No ChangeN/A1.7 $0.28
8/15/20231,700 shares $510.15 +240.0%N/A8.5 $0.30
7/31/2023500 shares $165.20 No ChangeN/A0 $0.33
7/15/2023500 shares $167.40 No ChangeN/A0 $0.33
6/30/2023500 shares $165.61 No ChangeN/A0.3 $0.33
6/15/2023500 shares $165.00 -37.5%N/A0.4 $0.33
5/31/2023800 shares $272.00 +60.0%N/A0.3 $0.34
5/15/2023500 shares $190.00 No ChangeN/A0.1 $0.38
4/30/2023500 shares $190.00 No ChangeN/A0.2 $0.38
4/15/2023500 shares $189.88 -80.8%N/A0.1 $0.38
3/31/20232,600 shares $995.80 -42.2%N/A0.7 $0.38
3/15/20234,500 shares $1,755.00 -25.0%N/A2.5 $0.39
2/28/20236,000 shares $2,640.00 +62.2%N/A1.4 $0.44
2/15/20233,700 shares $1,457.80 +2.8%N/A0.3 $0.39
1/31/20233,600 shares $1,260.00 +2.9%N/A1.2 $0.35
1/15/20233,500 shares $1,540.00 No ChangeN/A11.7 $0.44
12/30/20223,500 shares $1,461.25 No ChangeN/A5.8 $0.42
12/15/20223,500 shares $1,348.20 +133.3%N/A0.8 $0.39
11/30/20221,500 shares $574.50 +650.0%N/A0.3 $0.38
11/15/2022200 shares $86.00 No ChangeN/A0.1 $0.43
9/15/20221,300 shares $662.35 No ChangeN/A0.1 $0.51
6/15/20221,800 shares $1,083.60 +125.0%N/A0.2 $0.60
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

5/31/2022800 shares $647.60 -55.6%N/A0.1 $0.81
5/15/20221,800 shares $1,439.10 -88.5%N/A0.1 $0.80
4/30/202215,600 shares $12,324.00 +766.7%N/A0.7 $0.79
4/15/20221,800 shares $1,440.00 +1,700.0%N/A0.1 $0.80
3/31/2022100 shares $78.95 -97.2%N/A0 $0.79
3/15/20223,600 shares $3,024.00 +28.6%N/A0.3 $0.84
2/28/20222,800 shares $2,658.60 -42.9%N/A0.2 $0.95
2/15/20224,900 shares $4,753.00 No ChangeN/A0.1 $0.97
1/15/20223,300 shares $3,531.00 +22.2%N/A0.2 $1.07
12/31/20212,700 shares $2,808.00 +17.4%N/A0.1 $1.04
12/15/20212,300 shares $2,252.85 -54.0%N/A0.1 $0.98
11/30/20215,000 shares $4,947.50 +4,900.0%N/A0.1 $0.99
11/15/2021100 shares $92.50 -95.2%N/A0 $0.93
10/29/20212,100 shares $2,226.00 +600.0%N/A0.4 $1.06
10/15/2021300 shares $327.00 +50.0%N/A0 $1.09
9/30/2021200 shares $210.00 -50.0%N/A0 $1.05
9/15/2021400 shares $448.00 +33.3%N/A0 $1.12
8/31/2021300 shares $282.00 -90.3%N/A0 $0.94
8/13/20213,100 shares $2,974.45 +3,000.0%N/A0.1 $0.96
7/30/2021100 shares $104.00 -94.4%N/A0 $1.04
7/15/20211,800 shares $1,931.40 +50.0%N/A0.1 $1.07
6/30/20211,200 shares $1,320.00 -67.6%N/A0 $1.10
6/15/20213,700 shares $4,366.00 +516.7%N/A0.1 $1.18
5/28/2021600 shares $732.00 +500.0%N/A0 $1.22
5/14/2021100 shares $118.00 -75.0%N/A0 $1.18
4/30/2021400 shares $420.00 +100.0%N/A0 $1.05
4/15/2021200 shares $218.00 +100.0%N/A0 $1.09
3/31/2021100 shares $105.00 -91.7%N/A0 $1.05
3/15/20211,200 shares $1,152.00 -14.3%N/A0.1 $0.96
2/26/20211,400 shares $1,358.00 -70.8%N/A0 $0.97
2/12/20214,800 shares $4,608.00 -57.1%N/A0.1 $0.96
1/29/202111,200 shares $10,416.00 +1,020.0%N/A0.4 $0.93
1/15/202111,200 shares $9,072.00 +64.7%N/A0.8 $0.81
12/31/20202,500 shares $1,762.50 -77.7%N/A0.1 $0.71
12/15/202011,200 shares $8,904.00 +64.7%N/A0.8 $0.80
11/30/20206,800 shares $5,508.00 +3,300.0%N/A0.1 $0.81
11/15/2020200 shares $120.00 No ChangeN/A0.1 $0.60
9/30/2020200 shares $94.00 +100.0%N/A0 $0.47
9/15/2020100 shares $44.00 No ChangeN/A0 $0.44
8/31/2020100 shares $42.00 No ChangeN/A0 $0.42
8/14/2020100 shares $42.00 No ChangeN/A0.1 $0.42
7/15/20204,500 shares $2,128.50 +4,400.0%N/A1 $0.47
6/30/2020100 shares $45.00 -50.0%N/A0 $0.45
6/15/2020200 shares $96.00 +100.0%N/A0 $0.48
5/29/2020100 shares $48.50 -96.0%N/A0 $0.49
5/15/20202,500 shares $1,250.00 +47.1%N/A0.2 $0.50
4/30/20201,700 shares $714.00 No ChangeN/A0.1 $0.42
3/13/2020200 shares $69.96 No ChangeN/A0 $0.35
2/28/2020200 shares $73.00 No ChangeN/A0 $0.37
12/31/2019100 shares $24.30 No ChangeN/A0 $0.24
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…


INBP Short Interest - Frequently Asked Questions

What is Integrated BioPharma's current short interest?

Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 200 shares of INBP short. Learn More on Integrated BioPharma's current short interest.

Is Integrated BioPharma's short interest increasing or decreasing?

Integrated BioPharma saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 200 shares, a drop of 60.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Integrated BioPharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Integrated BioPharma: VolitionRx Limited (0.64%), Marker Therapeutics, Inc. (0.95%), Lexaria Bioscience Corp. (1.71%), Elevation Oncology, Inc. (11.90%), Avalon GloboCare Corp. (3.49%), Lantern Pharma Inc. (2.21%), Lumos Pharma, Inc. (5.41%), Surrozen, Inc. (1.90%), Daré Bioscience, Inc. (0.53%), BioLineRx Ltd. (0.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Integrated BioPharma stock?

Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Integrated BioPharma?

A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further.

How often is Integrated BioPharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:INBP) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners